Trump's "America First" ethos may come at a big cost to the stock market.

The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported ...

Taser maker Axon sees AI-related sales take off and its drone business gain momentum. Axon stock is near a buy point.

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

Leerink Partners upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a market perform rating to an ...

Regeneron Pharmaceuticals REGN +0.75% Get Free Report has outperformed the market over the past 20 years by 17.78% on an annualized basis producing an average annual return of 26.11%. Currently, ...

LOS ANGELES, CA / ACCESS Newswire / February 9, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...

U.S. Capital Wealth Advisors LLC lifted its holdings in shares of Eastman Chemical (NYSE:EMN – Free Report) by 4.3% during the 4th quarter, according to its most recent Form 13F filing with the ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Elsewhere, cell therapy developer Turnstone Biologics announced a second round of layoffs and plans to explore “strategic ...